Ivermectin for preventing and treating COVID‐19

M Popp, M Stegemann, MI Metzendorf… - Cochrane Database …, 2021 - cochranelibrary.com
Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

[HTML][HTML] Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19

P Kory, GU Meduri, J Varon, J Iglesias… - American journal of …, 2021 - journals.lww.com
Background: After COVID-19 emerged on US shores, providers began reviewing the
emerging basic science, translational, and clinical data to identify potentially effective …

Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19)

A Bhimraj, RL Morgan, AH Shumaker… - Clinical Infectious …, 2020 - academic.oup.com
Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

[HTML][HTML] ESCMID COVID-19 living guidelines: drug treatment and clinical management

M Bartoletti, O Azap, A Barac, L Bussini… - Clinical Microbiology …, 2022 - Elsevier
Abstract Scope In January 2021, the ESCMID Executive Committee decided to launch a new
initiative to develop ESCMID guidelines on several COVID-19-related issues, including …

[HTML][HTML] The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies

C Chakraborty, AR Sharma, M Bhattacharya… - Frontiers in …, 2021 - frontiersin.org
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …

Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial

J Vallejos, R Zoni, M Bangher, S Villamandos… - BMC infectious …, 2021 - Springer
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has changed
our lives. The scientific community has been investigating re-purposed treatments to prevent …

[HTML][HTML] Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines

A Bryant, TA Lawrie, T Dowswell… - American journal of …, 2021 - journals.lww.com
Ivermectin for Prevention and Treatment of COVID-19 Infectio... : American Journal of
Therapeutics Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic …

Ivermectin for the treatment of coronavirus disease 2019: a systematic review and meta-analysis of randomized controlled trials

YM Roman, PA Burela, V Pasupuleti… - Clinical Infectious …, 2022 - academic.oup.com
Background We systematically assessed benefits and harms of the use of ivermectin (IVM)
in patients with coronavirus disease 2019 (COVID-19). Methods Published and preprint …

Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study

S Abd‐Elsalam, RA Noor, R Badawi… - Journal of medical …, 2021 - Wiley Online Library
Researchers around the world are working at record speed to find the best ways to treat and
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …

[HTML][HTML] One year of coronavirus disease 2019 (COVID-19) in Brazil: a political and social overview

MN Boschiero, CVC Palamim, MM Ortega… - Annals of global …, 2021 - ncbi.nlm.nih.gov
Background: Coronavirus Disease 2019 (COVID-19) became the deadliest pandemic of the
new millennium. One year after it became a pandemic, the current COVID-19 situation in …